A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer

BACKGROUND: Carboxyamidotriazole (CAI), a calcium channel blocker, inhibits tumor cell proliferation, metastasis, and angiogenesis. This trial aimed to determine whether CAI combined with conventional chemotherapy could prolong progression-free survival (PFS) in non-small cell lung cancer (NSCLC) pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Xiaoyan, Wang, Jinwan, Cheng, Ying, Shi, Jianhua, Cui, Liying, Zhang, Helong, Huang, Yunchao, Liu, Wei, Chen, Lei, Zhu, Jiang, Zhang, Shucai, Li, Wei, Sun, Yan, Wang, Hanping, Zhang, Xiaotong, Wang, Mengzhao, Yang, Lin, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692340/
https://www.ncbi.nlm.nih.gov/pubmed/33281949
http://dx.doi.org/10.1177/1758835920965849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692340/
https://www.ncbi.nlm.nih.gov/pubmed/33281949
http://dx.doi.org/10.1177/1758835920965849

Ejemplares similares